BioAmber (BIOA) Tops Q1 EPS by 2c

BioAmber (NYSE: BIOA) reported Q1 EPS of ($0.25), $0.02 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $2.37 million.

For earnings history and earnings-related data on BioAmber (BIOA) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• DigitalOcean projects record Q2 2026 results with RPO above $800M
• LG Energy 2q Oper Profit 113.3b Won, Est. 210.66b Won - Bloomberg